Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Back

ESC Professional Premium Access

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Session: Drugs and devices in hypertension

Topic: Device Treatment and Intervention

Speaker: Doctor A. Moiseeva (Chisinau, MD)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Anna Moiseeva

Institute of Cardiology, Chisinau (Moldova (Republic of))

0 follower

7 more presentations in this session

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Speaker: Doctor M. Ibrahim (Flint, US)

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Speaker: Professor J. Wang (Shanghai, CN)

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Speaker: Professor N. Ntusi (Cape Town, ZA)

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Speaker: Associate Professor G. Abdullaeva (Tashkent, UZ)

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Speaker: Doctor E. Manta (Athens, GR)

Access the full session

Drugs and devices in hypertension

Speakers: Doctor A. Moiseeva, Doctor M. Ibrahim, Professor J. Wang, Professor N. Ntusi, Associate Professor G. Abdullaeva...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

About the speaker

Doctor Anna Moiseeva

7 more presentations in this session

The safety and efficacy of quadruple ultra-low-dose combination (quadpill) for hypertension treatment: a meta-analysis of randomized controlled trials

Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension

Comparing cardiovascular outcomes and costs of perindopril-, enalapril- or losartan-based antihypertensive regimens in South Africa: real-world medical claims database analysis

Neuroprotective efficacy of combined antihypertensive treatment with the inclusion of nitrendipine in patients with arterial hypertension

Effects of blood pressure lowering according to baseline cardiovascular disease: systematic review and meta-analysis of randomized trials

Access the full session

Drugs and devices in hypertension

About the event

ESC Congress 2023

ESC 365 is supported by